Results 151 to 160 of about 111,076 (331)

Drainage of Pleural Effusion in the Intensive Care Unit (DOPE‐ICU) Feasibility Trial—Protocol and Statistical Analysis Plan

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 5, May 2026.
ABSTRACT Pleural effusions are common in adult intensive care unit (ICU) patients with respiratory failure. Ultrasonography‐guided therapeutic pleural drainage is widely used and associated with improved oxygenation and ventilatory parameters, but no randomised clinical trial data exist.
Marie Schjødt Worm   +6 more
wiley   +1 more source

Mesothelioma [PDF]

open access: yesJournal of Thoracic Oncology, 2012
openaire   +2 more sources

Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients: A Multi‐Phase, Qualitative Focus Group and Co‐Production Study

open access: yesJournal of Advanced Nursing, Volume 82, Issue 5, Page 5096-5109, May 2026.
ABSTRACT Aim To design and develop a novel co‐produced intervention tool aimed at facilitating discussions that lung cancer nurses have with lung cancer patients about clinical trial opportunities; and promote trial recruitment. Design A multi‐phase qualitative focus group (phase 1) and co‐production (phase 2) study.
Christopher Dodd   +8 more
wiley   +1 more source

Correction: Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma [PDF]

open access: hybrid, 2021
Pierluigi Scalia   +4 more
openalex   +1 more source

YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR–HIF1α–LHDA Axis

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Breast cancer, a malignant tumour that frightens women, ruthlessly claims the lives of tens of thousands of women around the world every year. However, the mechanism by which YTHDF3 regulates the occurrence and development of breast cancer is still imperfect.
ZiQian Liu   +8 more
wiley   +1 more source

Epidemiology of Mesothelioma [PDF]

open access: gold, 2019
Domenica Cavone   +7 more
openalex   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

open access: yesMolecular Oncology, Volume 20, Issue 4, Page 933-946, April 2026.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy